Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses-Reference-Cited by-同舟云学术

Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses

Published:2015-10-07 Issue:5 Volume:22 Page:1103-1110
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Sundaresan Tilak K.,Sequist Lecia V.,Heymach John V.,Riely Gregory J.,Jänne Pasi A.,Koch Walter H.,Sullivan James P.,Fox Douglas B.,Maher Robert,Muzikansky Alona,Webb Andrew,Tran Hai T.,Giri Uma,Fleisher Martin,Yu Helena A.,Wei Wen,Johnson Bruce E.,Barber Thomas A.,Walsh John R.,Engelman Jeffrey A.,Stott Shannon L.,Kapur Ravi,Maheswaran Shyamala,Toner Mehmet,Haber Daniel A.

Funder

Stand Up To Cancer Dream Team Translational ResearchStand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 319 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors;Critical Reviews in Oncology/Hematology;2024-11

2. Unlocking the future of cancer diagnosis – promises and challenges of ctDNA-based liquid biopsies in non-small cell lung cancer;Translational Research;2024-10

3. Overview of the Role of Liquid Biopsy in Non-small Cell Lung Cancer (NSCLC);Clinical Oncology;2024-10

4. Clinical utility of repeated rebiopsy for EGFR T790M mutation detection in non-small cell lung cancer;Frontiers in Oncology;2024-08-26

5. Clinical applications of circulating biomarkers in non-small cell lung cancer;Frontiers in Cell and Developmental Biology;2024-08-21